BeStock  
Markets › Compare › PVLA vs XNCR

PVLA vs XNCR

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
PVLA · Palvella Therapeutics$132.16 ▼ 0.23%
XNCR · Xencor$25.63 ▲ 3.18%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

77121165209253Oct 7, '25Apr 7, '26Oct 5, '26
  • PVLA +86.9%
  • XNCR +113.1%

Head to head

MetricPVLAXNCR
Price$132.16$25.63
Change today▼ 0.23%▲ 3.18%
Market cap$1.90B$1.91B
Return, 3 months-9.3%+63.6%
Return, year to date+26.3%+67.4%
Return, 1 year+94.5%+117.4%
P/E (TTM)-27.2-11.9
P/B8.83.8
P/E percentile vs own 5y–12th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price+78.0%+30.5%
Analyst buy share100%91%
RSI (14)3356
30-day volatility37.5%52.7%
Max drawdown, 1 year-31.1%-42.6%
Trend readLeaning bearishStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • XNCR is the largest of the group by market value.
  • XNCR has returned the most over the past year.
  • PVLA carries the lowest trailing P/E.
  • PVLA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top